Cargando…

Streptococcus pneumoniae Serotype Distribution and Pneumococcal Conjugate Vaccine Serotype Coverage among Pediatric Patients in East and Southeast Asia, 2000–2014: a Pooled Data Analysis

Pneumococcal infection is one of the leading causes of death worldwide, especially in children of developing and underdeveloped countries. Capsular polysaccharide-based vaccines are available for the prevention of this disease. A 7-valent pneumococcal conjugate vaccine (PCV7) was licensed in 2000 fo...

Descripción completa

Detalles Bibliográficos
Autor principal:	Tai, Stanley S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810056/ https://www.ncbi.nlm.nih.gov/pubmed/26907356 http://dx.doi.org/10.3390/vaccines4010004

Ejemplares similares

Optimal Serotype Compositions for Pneumococcal Conjugate Vaccination under Serotype Replacement
por: Nurhonen, Markku, et al.
Publicado: (2014)

Serotype distribution of Streptococcus pneumoniae and pneumococcal vaccine coverage in adults in Turkey between 2015 and 2018
por: Hascelik, Gulsen, et al.
Publicado: (2022)

Decline in Vaccine-Type Streptococcus pneumoniae Serotypes Following Pneumococcal Conjugate Vaccine Introduction in Madagascar
por: Raboba, Julia L, et al.
Publicado: (2021)

2574. Serotype Distribution of Streptococcus pneumoniae and Pneumococcal Vaccine Coverage in Adults in Turkey between 2019 and 2022
por: Hasçelik, Gülşen, et al.
Publicado: (2023)

Impact of Pneumococcal Conjugate Vaccine on Vaccine Serotype–Specific Pneumonia
por: Klugman, Keith P, et al.
Publicado: (2020)

Serotypes in Adult Pneumococcal Pneumonia in Spain in the Era of Conjugate Vaccines
por: Fernández-Delgado, Lucía, et al.
Publicado: (2021)

High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi
por: Swarthout, Todd D., et al.
Publicado: (2020)

Streptococcus mitis Expressing Pneumococcal Serotype 1 Capsule
por: Lessa, Fernanda C., et al.
Publicado: (2018)

Streptococcus pneumoniae serotypes/serogroups causing invasive disease in Riyadh, Saudi Arabia: extent of coverage by pneumococcal vaccines
por: Al-Mazrou, Abdulrahman, et al.
Publicado: (2005)

Characterization of pneumococcal serotype 7F in vaccine conjugation
por: Deng, James Z, et al.
Publicado: (2023)

Selection of vaccine strains for serotype O foot-and-mouth disease viruses (2007–2012) circulating in Southeast Asia, East Asia and Far East
por: Mahapatra, Mana, et al.
Publicado: (2017)

Serotype Distribution of Clinical Streptococcus pneumoniae Isolates before the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Cambodia
por: Inghammar, Malin, et al.
Publicado: (2018)

Effect of Serotype on Focus and Mortality of Invasive Pneumococcal Disease: Coverage of Different Vaccines and Insight into Non-Vaccine Serotypes
por: van Hoek, Albert Jan, et al.
Publicado: (2012)

Empyema due to Streptococcus Pneumoniae Serotype 9V in a Child Immunized with 13-Valent Conjugated Pneumococcal Vaccine
por: Sütçü, Murat, et al.
Publicado: (2017)

Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites
por: Feikin, Daniel R., et al.
Publicado: (2013)

Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010–2015
por: Silva-Costa, Catarina, et al.
Publicado: (2018)

Invasive Streptococcus oralis Expressing Serotype 3 Pneumococcal Capsule, Japan
por: Chang, Bin, et al.
Publicado: (2022)

Serotype Distribution in Non-Bacteremic Pneumococcal Pneumonia: Association with Disease Severity and Implications for Pneumococcal Conjugate Vaccines
por: Benfield, Thomas, et al.
Publicado: (2013)

Changes in the Pneumococcal Vaccine Serotypes in Adult Noninvasive Pneumonia after the Introduction of Pneumococcal Conjugate Vaccination for Children
por: Takeda, Hiroaki, et al.
Publicado: (2019)

Revisitingmolecular serotyping of Streptococcus pneumoniae
por: Camargo, Dhian RA, et al.
Publicado: (2015)

Serotype-specific effectiveness against pneumococcal carriage and serotype replacement after ten-valent Pneumococcal Conjugate Vaccine (PCV10) introduction in Pakistan
por: Nisar, Muhammad Imran, et al.
Publicado: (2022)

Should Pneumococcal Serotype 3 Be Included in Serotype-Specific Immunoassays?
por: Linley, Ezra, et al.
Publicado: (2019)

Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Isolates Causing Invasive and Noninvasive Pneumococcal Diseases in Korea from 2008 to 2014
por: Kim, Si Hyun, et al.
Publicado: (2016)

Global Distribution of Invasive Serotype 35D Streptococcus pneumoniae Isolates following Introduction of 13-Valent Pneumococcal Conjugate Vaccine
por: Lo, Stephanie W., et al.
Publicado: (2018)

Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Severe Invasive Disease Caused by Serotype 3 Streptococcus Pneumoniae in Italian Children
por: Lodi, Lorenzo, et al.
Publicado: (2019)

The impact of serotype-specific vaccination on phylodynamic parameters of Streptococcus pneumoniae and the pneumococcal pan-genome
por: Azarian, Taj, et al.
Publicado: (2018)

Serotype 3 Remains the Leading Cause of Invasive Pneumococcal Disease in Adults in Portugal (2012–2014) Despite Continued Reductions in Other 13-Valent Conjugate Vaccine Serotypes
por: Horácio, Andreia N., et al.
Publicado: (2016)

Pneumococcal carriage and serotype distribution among children with and without pneumonia in Mozambique, 2014-2016
por: Adebanjo, Tolulope, et al.
Publicado: (2018)

Prevalent Multidrug-resistant Nonvaccine Serotypes in Pneumococcal Carriage of Healthy Korean Children Associated with the Low Coverage of the Seven-valent Pneumococcal Conjugate Vaccine
por: Lee, Sungkyoung, et al.
Publicado: (2013)

Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine
por: Patel, Sweta M., et al.
Publicado: (2022)

Serotype-specific Cardiac Involvement in Pneumococcal Pneumonia
por: Klugman, Keith P, et al.
Publicado: (2020)

Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015–2017
por: Nakano, Satoshi, et al.
Publicado: (2020)

Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia.
por: Hakanen, A, et al.
Publicado: (2001)

The 7-valent pneumococcal conjugate vaccine elicits cross-functional opsonophagocytic killing responses to Streptococcus pneumoniae serotype 6D in children
por: Lee, Hyunju, et al.
Publicado: (2013)

Nasopharyngeal carriage of Streptococcus pneumoniae serotypes among children in India prior to the introduction of pneumococcal conjugate vaccines: a cross-sectional study
por: Sutcliffe, Catherine G., et al.
Publicado: (2019)

1446. Correlation Between Adult Invasive and Noninvasive Streptococcus pneumoniae Disease in 13-Valent Pneumococcal Conjugate Vaccine Serotypes in the United States
por: Suaya, Jose A, et al.
Publicado: (2018)

Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50 Years and Older presenting with community-acquired pneumonia in Israel
por: Regev-Yochay, Gili, et al.
Publicado: (2018)

Pneumococcal Conjugate Vaccine Impact on Serotype 3: A Review of Surveillance Data
por: Sings, Heather L., et al.
Publicado: (2021)

Antibody enhanced HPLC for serotype-specific quantitation of polysaccharides in pneumococcal conjugate vaccine
por: Deng, James Z., et al.
Publicado: (2023)

Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Causing Invasive Pneumococcal Disease in Korea Between 2017 and 2019 After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine
por: Kim, Gyu Ri, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_171s55nfsbjft6thlu70utdmps